Learn More
Medchemexpress LLC 10-[[1-[(2,4-dichlorophenyl)methyl]indazole-3-carbonyl]amino]decyl-triphenylphosphanium;bromide | 2361564-49-8 | 97.0% | C43H45BrCl2N3OP | 10MG

Supplier: Medchemexpress LLC HY13483210MG
Mito-LND (Mito-Lonidamine) is a mitochondria-targeted inhibitor of oxidative phosphorylation used in preclinical research to disrupt mitochondrial bioenergetics, elevate reactive oxygen species, and trigger autophagic cell death in cancer models. It is supplied as a solid or as DMSO solution with defined purity and storage recommendations for laboratory use.
- Mitochondria-targeted OXPHOS inhibitor useful for studying mitochondrial metabolism.
- Induces reactive oxygen species and autophagic cell death in tumor cells.
- Available as solids and DMSO solutions in multiple pack sizes.
- High purity suitable for research applications.
- Stable under recommended sealed storage conditions at -20°C; longer-term stability in solvent at -80°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.